Group items tagged

The 2011 UMKC Pathology Breast Cancer Scandal was a cover-up of the prolonged, unsafe, ischemic times provided to women with breast cancer in the UMKC-TMC Pathology Department. Reports of unsafe patient care went neglected by the pathology chair, an attending, the residents, the DIO. I reported this to the ACGME in 2011 and in 2014 I discovered that the UMKC-Graduate Medical Education office lied to the ACGME about months of breast cancer care.

Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.

Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.

Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.

Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.

This article provides insight into the quality of medical regulation by a state medical board.